Substance / Medication

Pantoprazole

Overview

Active Ingredient
pantoprazole
RxNorm CUI
40790

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

31 trials linked to this intervention

31
Total Trials
3
Recruiting
8
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Pantoprazole and Vonoprazan Performed Well in Preventing Peptic Ulcer Recurrence in Low-Dose Aspirin Users.
An Haoyu, Chen Jing, Li Shicong et al. · Dig Dis Sci · 2024
PMID: 38252210Meta-Analysis
Intravenous pantoprazole as an adjuvant therapy following successful endoscopic treatment for peptic ulcer bleeding.
Wang Jun, Yang Kehu, Ma Bin et al. · Can J Gastroenterol · 2009
PMID: 19373423Meta-AnalysisFull text (PMC)
Pantoprazole provides rapid and sustained symptomatic relief in patients treated for erosive oesophagitis.
Bochenek W J, Mack M E, Fraga P D et al. · Aliment Pharmacol Ther · 2004
PMID: 15569113Meta-Analysis
Pantoprazole based therapies in Helicobacter pylori eradication: a systematic review and meta-analysis.
Gisbert Javier P, Khorrami Sam, Calvet Xavier et al. · Eur J Gastroenterol Hepatol · 2004
PMID: 15095858Meta-Analysis
Effect of pantoprazole as an adjunct to standard medical therapy in patients with uncomplicated amoebic liver abscess: A randomised pilot study.
Patel Rishabh, Kumar Ramesh, Priyadarshi Rajeev Nayan et al. · Trop Doct · 2025
PMID: 39743675RCT
Effect of Pantoprazole on the Absorption of Hydroxychloroquinea A Randomized Drug-Drug Interaction Trial in Healthy Adults.
Stoll Felicitas, Blank Antje, Mikus Gerd et al. · Clin Pharmacol Drug Dev · 2022
PMID: 34268908RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Pantoprazole (substance)
SNOMED CT
395821003
UMLS CUI
C0081876
RxNorm CUI
40790

Clinical Data

This intervention maps to 3 entities in the Ltrl knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
31
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.